Imipramine on ER+ve and Triple Negative Breast Cancer
Clinical trial NCT03122444 · COMPLETED
Trial details
- NCT number
- NCT03122444
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-05
- Primary completion
- 2022-03-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.